Oregon’s New Cannabis Laws: 2026 Edition – Canna Law Blog™ – Harris Sliwoski
Oregon cannabis regulatory changes 2026 will affect which cannabis products clinicians can recommend. These laws influence product availability, labeling, and safety standards. Clinicians must stay informed to guide patients effectively.
Michigan Supreme Court Asked to Rule on Marijuana Use and Probation
The Michigan Supreme Court is reviewing marijuana use and probation conditions amid state legalization. This case highlights conflicts between legal cannabis use and probation restrictions. Clinicians must understand these legal issues to advise patients…
State Closes Another Watertown Smoke Shop Over Youth-Targeted Products
Illegal cannabis retail enforcement remains a critical issue as state agencies close shops selling products appealing to children. These enforcement actions highlight ongoing challenges in cannabis retail regulation. Clinicians should be aware of the…
After Federal Court Win, Oklahoma Medical Marijuana Operators Fight State
Oklahoma medical marijuana legal challenges have intensified after a federal court victory for operators. These legal disputes focus on state regulatory overreach affecting patient access. Clinicians should monitor these developments as they impact the…
In the Mix: 8 More Articles — March 11, 2026
This article collection focuses on cannabinoid-based symptom management and its evolving clinical relevance. Recent developments highlight regulatory challenges and market dynamics. Clinicians must navigate these complexities carefully.
Texas Set to Ban Smokable Hemp THC Flower by March 31
The Texas hemp smokable THC ban will take effect on March 31, changing how hemp-derived THC flower is regulated. This policy impacts clinicians' ability to recommend smokable hemp products. Patients using these products should be counseled on…
In the Mix: 9 More Articles — March 11, 2026
This article reviews cannabis market consolidation and clinical trends in 2026. It highlights regulatory developments and CBD products for pain management. Cannabis market consolidation is shaping clinical applications and governance.
CED Digest: 230 Items — March 11, 2026
This CED Digest covers cannabis regulatory compliance challenges and the 2026 medical cannabis program launch. Clinicians will find insights on cannabinoid therapeutic applications and beverage industry enforcement. Stay informed on evolving regulations…
Florida Cannabis Legalization Measure Blocked from 2026 Ballot (Newsletter: March 11, 2026)
The florida cannabis legalization measure was blocked from the 2026 ballot, delaying patient access to regulated cannabis products. This setback may perpetuate reliance on unregulated cannabis with variable potency and contamination risks. Clinicians…
In the Mix: 7 More Articles — March 10, 2026
This update covers the cannabis research funding landscape and its impact on clinical and regulatory developments. Market expansion into minor cannabinoids and retail normalization are key themes. Enforcement patterns and psychoactive substance…